TITLE

A portable system for noninvasive assessment of advanced glycation end-products using skin fluorescence and reflectance spectrum

AUTHOR(S)
Wang, Y.; Zhu, L.; Zhang, L.; Zhang, G.; Liu, Y.; Wang, A.
PUB. DATE
July 2012
SOURCE
Journal of Applied Spectroscopy;Jul2012, Vol. 79 Issue 3, p431
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
An optical system has been developed for noninvasive assessment of skin advanced glycation end-products (AGEs). The system comprises mainly a high-power ultraviolet light emitting diode (LED) as an excitation source, an LED array for the reflectance measurement, a trifurcated fiber-optic probe for light transmitting and receiving, and a compact spectrometer for light detecting. Both skin fluorescence of a subject and the reflectance spectrum of the same site can be obtained in a single measurement with the system. Demonstrative measurements with the system have been conducted. Results indicate that the measured reflectance spectrum can be used to compensate for the distortion of AGEs fluorescence, which is caused by skin absorption and scattering. The system is noninvasive, portable, easy to operate, and has potential applications for clinical diagnosis of AGE-related diseases, especially diabetes mellitus.
ACCESSION #
79824115

 

Related Articles

  • Skin Autofluorescence Relates to Soluble Receptor for Advanced Glycation End-Products and Albuminuria in Diabetes Mellitus. Škrha Jr., J.; Šoupal, J.; Ekali, G. Loni; Prázný, M.; Kalousová, M.; Kvasnička, J.; Landová, L.; Zima, T.; Škrha, J. // Journal of Diabetes Research;2013, p1 

    The aim of this study was to compare skin autofluorescence caused by advanced glycation end-products (AGEs) with biochemical markers of endothelial dysfunction and soluble receptor for AGEs (sRAGE) in patients with diabetes. Skin autofluorescence (AF) assessed by AGE-Reader was evaluated with...

  • In vitro Antiglycation and Cross-Link Breaking Activities of Sri Lankan Low-Grown Orthodox Orange Pekoe Grade Black Tea (Camellia sinensis L). Ratnasooriya, Wanigasekara D.; Abeysekera, Walimuni K. S. M.; Muthunayake, Tharaka B. S.; Ratnasooriya, Chatura D. T. // Tropical Journal of Pharmaceutical Research;Apr2014, Vol. 13 Issue 4, p567 

    Purpose: To investigate the antiglycation and cross-link breaking activities of Sri Lankan low-grown orthodox Orange Pekoe grade black tea (Camellia sinensis L) Methods: Five concentrations (6.25, 12.5, 25.0, 50.0 or 100.0 µg/ml) of Black tea brew (BTB) were made using Sri Lankan low-grown...

  • Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress. Qin Wei; Xiaomei Ren; Yibo Jiang; Hong Jin; Naifeng Liu; Jie Li // BMC Cardiovascular Disorders;2013, Vol. 13 Issue 1, p1 

    Background: Arterial media calcification (AMC) is highly prevalent and is a major cause of morbidity, mortality, stroke and amputation in patients with diabetes mellitus (DM). Previous research suggests that advanced glycation end products (AGEs) are responsible for vascular calcification in...

  • COMPLICATIONS IN PEDIATRIC DIABETES.  // Diabetes;2015 Supplement, Vol. 64, pA16 

    The article presents abstracts on medical topics, which include the circulating soluble receptor for advanced glycation end products (s-RAGE) as a biomarker of glycemia and subclinical atherosclerosis in youth, sex-specific body fat thresholds for accumulating visceral fat in children, and the...

  • Hidden Complexities in the Measurement of Fructosyl-Lysine and Advanced Glycation End Products for Risk Prediction of Vascular Complications of Diabetes. Rabbani, Naila; Thornalley, Paul J. // Diabetes;Jan2015, Vol. 64 Issue 1, p9 

    A review of the articles on furosine and advanced glycation end products (AGEs) measurement, pentosidine residues in plasma protein of type 2 diabetic patients, and fructosyl-lysine levels in relation to vascular complications of diabetes published in various issues of "Diabetes," is presented.

  • Statement of Retraction.  // Diabetes;May2014, Vol. 63 Issue 5, p1817 

    A retraction to the article "Receptor for Advanced Glycation End Products (RAGEs) and Experimental Diabetic Neuropathy" that was published in a 2008 issue is presented.

  • Statement of Retraction.  // Diabetes;May2014, Vol. 63 Issue 5, p1817b 

    A retraction to the article "Blockade of Receptor for Advanced Glycation End Products in a Model of Type 1 Diabetic Leukoencephalopathy" that was published in a November 2012 issue is presented.

  • C-reactive protein advanced glycation end products, and their receptor in type 2 diabetic, elderly patients with mild cognitive impairment. Gorska-Ciebiada, Malgorzata; Saryusz-Wolska, Malgorzata; Borkowska, Anna; Ciebiada, Maciej; Loba, Jerzy // Frontiers in Aging Neuroscience;Oct2015, Vol. 7, p1 

    Objective: The aim of the study was to evaluate serum levels of advanced glycation end products (AGEs), receptor for advanced glycation end products (RAGE), and C-reactive protein (CRP) in elderly patients with type 2 diabetes mellitus with and without mild cognitive impairment (MCI) and to...

  • Inhibition of AGEs formation by natural products. Nagai, Ryoji; Shirakawa, Jun-ichi; Ohno, Rei-ichi; Moroishi, Narumi; Nagai, Mime // Amino Acids;Feb2014, Vol. 46 Issue 2, p261 

    Since advanced glycation end-products (AGEs) inhibitors such as benfotiamine, pyridoxamine and aminoguanidine significantly inhibit the development of retinopathy and neuropathy in streptozotocin-induced diabetic rats, treatment with AGEs inhibitors is believed to be a potential strategy for...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics